Last edited by Taur
Tuesday, July 28, 2020 | History

1 edition of Studies on pneumococcus immunity. found in the catalog.

Studies on pneumococcus immunity.

Studies on pneumococcus immunity.

  • 304 Want to read
  • 25 Currently reading

Published by G.P.O. in Washington .
Written in English

    Subjects:
  • Immunity.,
  • Streptococcus pneumoniae.

  • Edition Notes

    SeriesBulletin / Hygienic Laboratory -- no. 141, Bulletin of the Hygienic Laboratory -- no. 141.
    ContributionsCecil, Russell L. 1881-1965., Hygienic Laboratory (U.S.)
    Classifications
    LC ClassificationsRA421 .U4 no. 141
    The Physical Object
    Paginationiv, 78 p. :
    Number of Pages78
    ID Numbers
    Open LibraryOL22974362M
    LC Control Number25026540

      After many years of study, including one involving nea children in the Kaiser Permanent health care system, a new form of pneumococcal vaccine was released. In this vaccine, Prevnar [Wyeth-Lederle], capsular polysaccharide from 7 of the most common pneumococcal types were conjugated to a protein that closely resembles diphtheria toxoid. Sir Almroth Wright coordinated the first trial of a whole-cell pneumococcal vaccine in South Africa from to Wright started a chain of events that delivered pneumococcal vaccines of increasing clinical and public-health value, as medicine advanced from a vague understanding of the germ theory of disease to today's rational vaccine design.

    Mario Ramirez, in Molecular Medical Microbiology (Second Edition), Pneumococcal Vaccines. Pneumococcal vaccines have a rich history that extends over years [15,].Pioneering work was done with both whole-cell and CPS-based formulations. This involved large clinical trials that were hampered by problems in their implementation and a still-evolving knowledge of pneumococcal . Download Citation | On Jan 1, , S. Sjöstedt and others published STUDIES IN PNEUMOCOCCAL IMMUNITY III.: DETERMINATION OF THE RESISTANCE OF PNEUMOCOCCI TO SULPHAPYRIDINE | Find, read and cite.

    Russell L. Cecil, Gustav I. Steffen; STUDIES ON PNEUMOCOCCUS IMMUNITY: II. A CTIVE I MMUNIZATION OF M ONKEYS AGAINST P NEUMOCOCCUS T YPES II, III, AND IV P NEUMONIA WITH THE H OMOLOGOUS P NEUMOCOCCUS V ACCINE. Studies on the Nature of the Immunity ReactionI. An Experimental Study of Pneumococcal Immunity Armstrong, Richard R. Abstract. Publication: Proceedings of the Royal Society of London Series B. Pub Date: November Bibcode: RSPSBA full text sources. Publisher |.


Share this book
You might also like
James Madison rules America

James Madison rules America

FIN25024 MOONLIGHT SONATA

FIN25024 MOONLIGHT SONATA

Chiltons Auto Repair Manual 1986

Chiltons Auto Repair Manual 1986

Student concerto no. 2, for viola in the first position with piano acc.

Student concerto no. 2, for viola in the first position with piano acc.

Assessors land valuations

Assessors land valuations

Bearing down.

Bearing down.

Privy Council registers

Privy Council registers

Messrs. Peter Walker & Sons, King Street Brewery, Warrington.

Messrs. Peter Walker & Sons, King Street Brewery, Warrington.

Technical service data

Technical service data

Haggadah for Passover.

Haggadah for Passover.

The chocolate heiress

The chocolate heiress

Reading skill acquisition

Reading skill acquisition

St. Petersburg Atlas

St. Petersburg Atlas

Spider

Spider

Ohio school bus minimum standards

Ohio school bus minimum standards

Maia.

Maia.

Studies on pneumococcus immunity Download PDF EPUB FB2

Cecil rl, steffen gi. studies on pneumococcus immunity: i. active immunization of monkeys against pneumococcus type i pneumonia with pneumococcus type i vaccine.

j exp med. aug 31; 34 (3)– [pmc free article]Cited by: 5. cecil rl, steffen gi. studies on pneumococcus immunity: i. active immunization of monkeys against pneumococcus type i pneumonia with pneumococcus type i vaccine.

j exp med. aug 31; 34 (3)– [pmc free article] jobling jw, strouse s. studies on ferment action: v. immunization with proteolytic cleavage products of by: 1. The subcutaneous inoculation of monkeys with three large doses of Pneumococcus Type I vaccine confers on them a complete immunity against experimental Pneumococcus Type I pneumonia.

The intravenous inoculation of small doses of Pneumococcus Type I vaccine also confers complete immunity against the homologous type of pneumonia. by:   cecil rl, steffen gi.

studies on pneumococcus immunity: i. active immunization of monkeys against pneumococcus type i pneumonia with pneumococcus type i vaccine. j exp med. aug 31; 34 (3)– [pmc free article] jobling jw, strouse s. studies on ferment action: v.

immunization with proteolytic cleavage products of pneumococci. Pneumococcus antigen is therefore carried within or adheres to the protein fraction of the organism.

Pneumococcus antigen is resistant to prolonged autolysis and to tryptic digestion, and can be recovered from the soluble portions of digests of either the intact bacteria or the bacterial protein.

STUDIES ON PNEUMOCOCCUS IMMUNITY STUDIES ON PNEUMOCOCCUS IMMUNITY Cecil, Russell L.; Steffen, Gustav I. (Received for publication, Ma ) I n a previous communication (1) it has been shown t h a t the subcutaneous or intravenous injection of monkeys with Pneumococcus T y p e I vaccine confers on t h e m a complete i m m u n i t y against.

tillett ws. studies on immunity to pneumococcus mucosus (type iii): ii. the infectivity of type iii pneumococcus for rabbits. j exp med. may 31; 45 (6)– [pmc free article] enders jf, wu cj. an immunological study of the a substance or acetyl polysaccharide of pneumococcus type i. j exp med.

jul 31; 60 (2)– tillett ws. studies on immunity to pneumococcus mucosus (type iii): ii. the infectivity of type iii pneumococcus for rabbits. j exp med. may 31; 45 (6)– [pmc free article] []watson el, cooper g.

the production of infection with pneumococci in rabbits by intradermal inoculation of type iii pneumococci, the treatment with specific antiserum, and a comparison with type i infections.

Studies evaluating immunogenicity of valent conjugate pneumococcal vaccine (PCV13) in adults in sequential dosing. Guidelines for use of the valent conjugate pneumococcal vaccine (PCV13) in.

STUDIES ON PNEUMOCOCCUS IMMUNITY: I. ACTIVE IMMUNIZATION OF MONKEYS AGAINST PNEUMOCOCCUS TYPE I PNEUMONIA WITH PNEUMOCOCCUS TYPE I VACCINE. (PMID PMCID:PMC) Full Text Citations ; BioEntities ; Related Articles ; External Links ; J Exp Med.

August 31; 34(3): – Contributors. Reviews. Close X Reading View. The Pneumococcus is a state-of-the-art examination of recent research in this field and the impact of this gram-positive pathogen on human disease.

Long known as a severe, invasive pathogen, the threat level of the pneumococcus is on the rise due to high-level antibiotic resistance. STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III IV. OBSERVATIONS ON A NON-TYPE SPECIFIC HUMORAL FACTOR INVOLVED IN RESISTANCE TO PNEUMOCOCCUS TYPE III BY JOHN F.

ENDERS, ProD., CHAO-JEN WU,* M.D., AND MORRIS F. SHAFFER,* PH,D. (From the Department of Bacteriology and Immunology, The Harvard. Streptococcus pneumoniae remains a significant cause of morbidity and mortality worldwide. It causes a variety of diseases, ranging from mild otitis media to invasive disease, including sepsis and meningitis.

Colonization of the nasopharynx is a prerequisite for invasive pneumococcal disease and also an important step in the development of antimicrobial resistance.

development of natural immunity is poorly understood. Clinical Features The major clinical syndromes of pneumococcal disease are pneumonia, bacteremia, and meningitis.

Pneumococcal pneumonia is the most common clinical presentation of pneumococcal disease among adults. The incubation period of pneumococcal pneumonia is short, about 1 to 3 days. studies on pneumococcus immunity: ii. active immunization of monkeys against pneumococcus types ii, iii, and iv pneumonia with the homologous pneumococcus vaccine.

cecil rl, steffen gi. j exp med, 38(2), 01 jul cited by. STUDIES ON PNEUMOCOCCUS IMMUNITY STUDIES ON PNEUMOCOCCUS IMMUNITY Perlzweig, William A.; Steffen, Gustav I. Active immunity against many lethal doses of Pneumococcus Types I, II, and III may be produced in mice by two or three subcutaneous injections of the homologous type of pneumococcus saline vaccine.

an immunological study of pneumococcus mucosus STUDIES OF THE PNEUMOCOCCUS AND ALLIED ORGANISMS WITH REFERENCE TO THEIR OCCURRENCE IN THE HUMAN MOUTH A CASE OF GENERAL GASEOUS EMPHYSEMA WITH GAS CYSTS IN THE BRAIN FORMED AFTER DEATH AND DUE TO BACILLUS MUCOSUS CAPSULATUS, WITH A CONSIDERATION OF THE.

STUDIES ON PNEUMOCOCCUS IMMUNITY STUDIES ON PNEUMOCOCCUS IMMUNITY Cecil, Russell L.; Steffen, Gustav I. The subcutaneous inoculation of monkeys with three large doses of Pneumococcus Type I vaccine confers on them a complete immunity against experimental Pneumococcus Type I pneumonia.

An Experi- mental Study of Pneumococcal Immunity. By RICHARD R. ARMSTRONG, M.D., M.R.C.P. (Communicated by Sir Frederick Andrewes, ved, April 8, ).

cecil rl, steffen gi. studies on pneumococcus immunity: i. active immunization of monkeys against pneumococcus type i pneumonia with pneumococcus type i vaccine. j exp med. aug 31; 34 (3)– [pmc free article]. UGA researcher Balázs Rada is the principal investigator on two NIH-funded projects totaling $M.

Rada and his team will study the body’s innate immune response to influenza and a pneumonia-causing bacterium, Streptococcus pneumoniae, also known as pneumococcus. Epithelial cells are common in the body. They cover all body surfaces, line body cavities and hollow organs, and .studies on pneumococcus infection in animals: s econd p aper: a ction of i mmune s era on p neumococcus i nfection.

Augustus B. Wadsworth From the Department of Bacteriology of Columbia University, College of Physicians and Surgeons, New York.A consensus of the importance of the bacterial capsule for protective immunity has prevailed from very early on, based on the serotype specificity of the first whole-cell vaccines and soon after that on the protective immunity observed after vaccination with the purified polysaccharide.

The evidence of serotype-specific protection against bacteremia in immunocompetent adults, starting.